comparemela.com
Home
Live Updates
Korea Hemophilia Foundation - Breaking News
Pages:
Latest Breaking News On - Korea hemophilia foundation - Page 1 : comparemela.com
Thrombotic AEs of Hemlibra (emicizumab) were 2 8 times more frequent than those of FVIII replacements
/PRNewswire/ GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced on August 17, 2023 that it has presented the results of analyzing.
South korea
United states
South korean
Ju young shin
Seunghyun baek
Thromb haemost
Young yoo
Bongkyoo choi
Yelin jun
Sohee kim
Drug administration
Sungkyunkwan university
Department of research
National hemophilia foundation
Korea hemophilia foundation
Green cross corporation
vimarsana © 2020. All Rights Reserved.